Substituted aryl sulfone derivatives as calcium channel blockers

Details for Australian Patent Application No. 2008307572 (hide)

Owner Merck Sharp & Dohme Corp. Neuromed Pharmaceuticals Ltd.

Inventors Tyagarajan, Sriram; Pajouhesh, Hassan; Ye, Feng; Duffy, Joseph L.; Shao, Pengcheng Patrick; Chakravarty, Prasun K.; Ding, Yanbing

Agent Spruson & Ferguson

Pub. Number AU-A-2008307572

PCT Pub. Number WO2009/045382

Priority 60/997,615 04.10.07 US

Filing date 30 September 2008

Wipo publication date 9 April 2009

International Classifications

A01N 43/40 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/045382 Priority application(s): WO2009/045382

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307573-Production of monatin stereoisomers

2008307571-N-substituted oxindoline derivatives as calcium channel blockers